Abstracts
Permanent URI for this collection
Browse
Browsing Abstracts by Subject "Alzheimer's disease"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Open Access Adiponectin plasma levels in patients with age-related dementia(2016-05) Kaiyrlykyzy, A.; Umbayev, B.; Masoud, A.; Shramko, A.; Idrissova, D.; Zhussupova, A.; Alzhanova, D.; Alimbetov, D.; Askarova, S.Adiponectin play a significant role in the regulation of type 2 diabetes, obesity, atherosclerosis, non-alcoholic fatty liver disease and neurodegenerative disorders. Evidence suggests that adiponectin may be an independent risk factor for all-cause dementia and Alzheimer's disease (AD) and the level of adiponectin in plasma reflects its level in cerebrospinal fluid (CSF). Studies demonstrated that elevated adiponectin level in blood was associated with an increased risk of dementia and AD in women and indicates that the sex dimorphism with regard to adiponectin levels association with Alzheimer's disease was clearly observedItem Open Access Role of astrocyte aging in the pathogenesis of alzheimer`s disease(National Laboratory Astana, NAZARBAYEV UNIVERSITY, 2016-05) Imangali, N.; Alimbetov, D.; Tsoy, A.; Saparbayev, S.; Askarova, Sh.Alzheimer's disease (AD) is the most abundant severe and irreversible neurodegenerative disease in the world that affects people over 65 years old. The major hallmarks of AD pathology are the senile p-amyloid plaques, hyperphosphorylated neurofibrillary tangles, accompanied by severe neuroinflammation, synaptic disruption, neuronal degeneration and apoptosis, eventually triggering cerebral atrophy, memory loss and cognitive decline. The deposition and increase of p-amyloid levels in the brain induce the cascade of signals triggering production of neurotoxic molecules such as reactive oxygen species, nitric oxide, and proinflammatory cytokines and chemokines that cause neuroinflammation and neurodegeneration eventually resulting into dementia. Aging is the key risk factor for many inflammatory diseases including AD. However, the correlation of aging and AD is poorly investigated. Especially, the cytotoxic effects of p-amyloid in aging glial cells have been poorly explored. Human astrocytes are the most abundant CNS cells that undergo senescence with age and in response to stress. Therefore, it is hypothesized that sensitivity to p-amyloid may significantly change during in vitro senescence of astrocytes. The aim of this study is to investigate the mechanisms of cytotoxic actions of p-amyloid peptide in senescent astrocytes.